Challenges of thyroid cancer management in amiodarone-treated patients: a case report

Thyroid carcinoma (TC) is the most common endocrine malignancy. Although the overall prognosis for patients with TC is good, up to 20-30% of patients have recurrent or persistent disease after conventional therapy by surgical resection and radioactive iodine (RAI). Amiodarone is a highly efficient a...

Full description

Saved in:
Bibliographic Details
Published inClujul medical Vol. 88; no. 4; pp. 550 - 554
Main Authors Petrulea, Mirela Sanda, Lencu, Codruta, Piciu, Doina, Lisencu, Cosmin Ioan, Georgescu, Carmen Emanuela
Format Journal Article
LanguageEnglish
Published Romania Iuliu Hatieganu University of Medicine and Pharmacy 2015
Subjects
Case Reports
thyroid cancer
radioiodine
amiodarone
lymph nodes dissection
Online AccessGet full text

Cover

More Information
Summary:Thyroid carcinoma (TC) is the most common endocrine malignancy. Although the overall prognosis for patients with TC is good, up to 20-30% of patients have recurrent or persistent disease after conventional therapy by surgical resection and radioactive iodine (RAI). Amiodarone is a highly efficient anti-arrhythmic drug with a very long half-life, so it may interfere with RAI many months after the drug withdrawal. This case report mirrors the challenges of thyroid cancer management in an amiodarone-treated patient.
ISSN:1222-2119
2066-8872
DOI:10.15386/cjmed-502